Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling. | J Pharmacol Exp Ther;331(2): 690-9, 2009 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling.

Masood, Anbrin; Huang, Ying; Hajjhussein, Hassan; Xiao, Lan; Li, Hao; Wang, Wei; Hamza, Adel; Zhan, Chang-Guo; O'Donnell, James M.

Affiliation

Masood A; Departments of Behavioral Medicine and Psychiatry and Neurobiology and Anatomy, West Virginia University Health Sciences Center, Morgantown, West Virginia 26506, USA.

J Pharmacol Exp Ther ; 331(2): 690-9, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19684253

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase Inhibitors / Anti-Anxiety Agents / Cyclic GMP / Exonucleases Type of study: Risk_factors_studies Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 2009 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase Inhibitors / Anti-Anxiety Agents / Cyclic GMP / Exonucleases Type of study: Risk_factors_studies Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 2009 Document type: Article Affiliation country: